the Effects of Perioperative Goal Directed and Conventional Fluid Management on the IVC Collapsibility Index
Femoral Neck Fractures
About this trial
This is an interventional health services research trial for Femoral Neck Fractures focused on measuring intraoperative care, hemodynamic monitoring, fluid therapy
Eligibility Criteria
Inclusion Criteria:
- 65 years and older
- 1-3 ASA anesthesia risk
- Planned to undergo proximal femoral surgery due to intertochanteric fracture
Exclusion Criteria:
- cardiac arrhythmia,
- chronic renal failure and those on dialysis,
- heart failure,
- aortic insufficiency,
- active lower/upper respiratory tract infections,
- inferior vena cava cannot be clearly visualized by USG, BMI>35, Patients in need of postoperative intensive care or ASA4, Patients with advanced obstructive or restrictive respiratory diseases, Patients under 65 years of age.
Sites / Locations
- Fatih Sultan Mehmet Research and Training Hospital
Arms of the Study
Arm 1
Arm 2
Active Comparator
No Intervention
Grup HYT
Grup KON
The group (GRUP HYT) to be treated with targeted fluid therapy will be monitored with a Mostcaretm (Vygon, VytechHealth, Padova, Italy) pulse contour hemodynamic monitor after arterial cannulation. Cardiacindex (CI), stroke volume variance (SVV), pulse pressure variance (PPV), systemic vascular resistance (SVR), systemic vascular resistance index (SVRI), oxygen delivery (Do2), arterial elastance (Ea) measurements and mean arterial pressure Every 5 minutes to be followed, fluid therapy will be planned in accordance with our algorithm.
Fluid deficit due to fasting time will be calculated in accordance with the 4-2-1 rule for patients in Group KON. half of the calculated fluid volume in the first hour; the remaining half will be given at the 2nd and 3rd Hours. (4ml/kg/hr for the first 10 kilograms, 2ml/kg/hr for the second 10 kg, 1ml/kg/hr for each subsequent kilogram). Maintenance fluid will be considered as a medium-sized surgical trauma and will be given at 4 ml/kg/hr. Hemorrhages will be replaced with 3 times the blood loss with balanced crystalloid or 1 times HES.